Ipsogen has launched MapQuant Dx HER2 test. Developed on the MapQuant Dx microarray diagnostic platform, MapQuant Dx HER2 measures a set of HER2-amplified genes that correlate with HER2 protein expression. This new HER2 test provides reliable, intelligible and decisive information for pathologists, oncologists and patients.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
4 August, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 August, 2026
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026
UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
